1,001 results on '"Pradere B"'
Search Results
2. Parcours de réhabilitation par le binôme IDE-urologue avant et après prostatectomie (REHAB) : étude de faisabilité
3. Photocoagulation with GREENLIGHT© laser in radiation-induced haemorrhagic cystitis: Results of a single-center series
4. The current role of precision surgery in oligometastatic prostate cancer
5. French AFU Cancer Committee Guidelines – Update 2022–2024: Upper urinary tract urothelial cancer (UTUC)
6. French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
7. French AFU Cancer Committee Guidelines – Update 2022–2024: Muscle-Invasive Bladder Cancer (MIBC)
8. Reconnaissance endoscopique des anomalies papillaires et des calculs urinaires (REPC) : comment et quel intérêt ?
9. Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery
10. Tratamiento quirúrgico a cielo abierto y por vía laparoscópica del reflujo vesicorrenal en adultos
11. Trattamento chirurgico a cielo aperto e per via laparoscopica del reflusso vescicorenale negli adulti
12. Résultats périopératoires de la radiofréquence sur les petites tumeurs du rein : complications, impact sur la fonction rénale et résultats oncologiques
13. The volume and thickness of preprostatic fat on MRIs are not associated with prostate cancer aggressiveness in men undergoing radical prostatectomy
14. Recommandations du Comité de cancérologie de l’Association Française d’Urologie (CC-AFU) pour la bonne pratique des instillations intravésicales de mitomycine C, d’épirubicine et de BCG pour le traitement des tumeurs de la vessie n’infiltrant pas le muscle (TVNIM)
15. Complications tardives après traumatisme fermé du rein : résultats de l’étude observationnelle nationale multicentrique TraumAFUF
16. Recommandations des Comités de cancérologie (CC-AFU) et d’infectiologie (CI-AFU) de l’Association française d’urologie pour la prise en charge effets indésirables et complications du BCG
17. Évaluation des connaissances en anatomie uro-génitale des urologues en formation
18. TORSAFUF – Surgical exploration for torsion of spermatic cord suspicion and risk factors for unnecessary surgery: Results of a French nationwide retrospective study on 2940 patients
19. Multicenter external validation of the radical cystectomy pentafecta in a European cohort of patients undergoing robot-assisted radical cystectomy with intracorporeal urinary diversion for bladder cancer
20. The impact of venous thromboembolism on bladder cancer patients undergoing open or minimally-invasive radical cystectomy in the United States: Perioperative outcomes and health-care costs from insurance claims data
21. Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort
22. Repeat Transurethral Resection for Non-muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era
23. The optimal way to determine kidney function for cisplatin-based neoadjuvant chemotherapy in muscle-invasive bladder cancer: A European Association of Urology young academic urologists urothelial cancer working group multi-institutional study
24. Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: A systematic review, meta-analysis, and network meta-analysis
25. Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: A meta-analysis
26. Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels
27. Natural history of cN+ bladder cancer treated with radical cystectomy with or without perioperative treatment
28. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
29. The optimal number of induction chemotherapy cycles in cN+ bladder cancer
30. Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer
31. Diagnostic accuracy of liquid biomarkers for clinically significant prostate cancer detection: A systematic review and diagnostic meta-analysis of multiple thresholds
32. Risk of upper urinary tract dissemination in cT3 bladder cancer patients treated with Double J stent versus nephrostomy tube prior to radical cystectomy
33. Addition of neoadjuvant chemotherapy to a quadrifecta composite improves the oncologic outcomes reporting of patients treated with radical cystectomy for bladder cancer
34. Oncologic outcomes of endoscopic management of upper tract urothelial carcinoma: A systematic review and pooled analysis from the EAU-YAU Urothelial Working Group
35. Educational program in onco-urology for young urologists: What are their needs?
36. Residents and patients benefit from surgical simulation on a live porcine model, could we consider it as ethical?
37. Traitement chirurgical et interventionnel de l’obstruction sous-vésicale liée à une hyperplasie bénigne de prostate : revue systématique de la littérature et recommandations de bonne pratique clinique du Comité des Troubles Mictionnels de l’Homme
38. Mise au point sur les nouvelles techniques chirurgicales et interventionnelles dans la prise en charge de l’obstruction sous-vésicale liée à l’hyperplasie bénigne de la prostate
39. Analyse des coûts de la photovaporisation prostatique au laser Greenlight versus résection transurétrale de la prostate : intérêt de la prise en charge ambulatoire
40. Die Ergänzung einer neoadjuvanten Chemotherapie zu einem Quadrifekta-Komposit verbessert die onkologische Ergebnisberichterstattung von Patienten, die wegen Blasenkrebs mit radikaler Zystektomie behandelt wurden
41. COVID19 pandemic impacts on anxiety of French urologist in training: Outcomes from a national survey
42. The role of device-assisted therapies in the management of non-muscle invasive bladder cancer: A systematic review
43. Prognostic factors after adrenalectomy for adrenal metastasis
44. Traumatismes du rein
45. Patients avec un cancer de la prostate traités par hormonothérapie : impact de l’activité physique adaptée
46. Place de la médecine nucléaire au sein de la prise en charge du cancer de la prostate
47. Absence of Tumor (T0) on Second Transurethral Resection (ReTURB) Positively Impact Recurrence and Progression Risk Dynamics in a Contemporary Series of High-grade T1 Non-muscle Invasive Bladder Carcinoma Treated With Adequate Bacillus Calmette-Guérin
48. Cisplatin Eligibility in the Neoadjuvant Setting for Patients with Muscle-Invasive Bladder Cancer: The Optimal Way to Determine Kidney Function
49. Enhancing Predictions of the EAU21 Scoring Model in High-Grade Non-Muscle Invasive Bladder Carcinoma Treated with BCG using Explainable Machine Learning Survival Ensemble
50. Robot-assisted renal transplantation using the retroperitoneal approach (RART) with more than one year follow up: Description of the technique and results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.